Article info
Myositis
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis
- Correspondence to Dr Andrew Lee Mammen, Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892, USA; andrew.mammen{at}nih.gov; Dr Iago Pinal-Fernandez, Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA; iago.pinalfernandez{at}nih.gov
Citation
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis
Publication history
- Received December 20, 2022
- Accepted February 8, 2023
- First published February 17, 2023.
Online issue publication
May 11, 2023
Article Versions
- Previous version (17 February 2023).
- Previous version (7 March 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.